NOVOTECH HEALTH Trademark

Trademark Overview


On Monday, October 26, 2020, a trademark application was filed for NOVOTECH HEALTH with the United States Patent and Trademark Office. The USPTO has given the NOVOTECH HEALTH trademark a serial number of 79311087. The federal status of this trademark filing is REGISTERED as of Tuesday, February 15, 2022. This trademark is owned by Novotech (Australia) Pty Ltd. The NOVOTECH HEALTH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

conducting clinical trials for others; conducting and managing clinical trials for others in the field of pharmaceuticals, biotechnology and other related industries; conducting clinical trials for others [scientific research]; providing medical and scientific research information about the results of clinical trials in the nature of clinical trials for pharmaceuticals and biotechnology; scientific research; medical research; preparation of statistics, namely, scientific analysis in the field of clinical trial results for scientific research; preparation of biostatistics, namely, scientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clini...
novotech health

General Information


Serial Number79311087
Word MarkNOVOTECH HEALTH
Filing DateMonday, October 26, 2020
Status700 - REGISTERED
Status DateTuesday, February 15, 2022
Registration Number6641668
Registration DateTuesday, February 15, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements


Disclaimer with Predetermined Text"HEALTH"
Goods and Servicesconducting clinical trials for others; conducting and managing clinical trials for others in the field of pharmaceuticals, biotechnology and other related industries; conducting clinical trials for others [scientific research]; providing medical and scientific research information about the results of clinical trials in the nature of clinical trials for pharmaceuticals and biotechnology; scientific research; medical research; preparation of statistics, namely, scientific analysis in the field of clinical trial results for scientific research; preparation of biostatistics, namely, scientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely, medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits, namely, quality evaluation of site compliance with clinical trial protocols and standards; preparation of reports and applications to regulators relating to aspects of clinical trials, namely, providing medical and scientific information and data in the field of conducting clinical trials; provision of medical and scientific research information and data between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards, namely, preparation of reports and applications on the quality and standard of clinical trials; technical writing of clinical report forms which are required by clinical trial drug protocols

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovotech (Australia) Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameNovotech (Australia) Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameNovotech (Australia) Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Tuesday, August 16, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 22, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 22, 2022FINAL DISPOSITION PROCESSED
Sunday, May 15, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 15, 2022REGISTERED-PRINCIPAL REGISTER
Monday, December 6, 2021NOTIFICATION PROCESSED BY IB
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 17, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 28, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, October 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 28, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, October 28, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, September 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 28, 2021REFUSAL PROCESSED BY IB
Thursday, June 10, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, June 10, 2021REFUSAL PROCESSED BY MPU
Wednesday, June 9, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 8, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 25, 2021APPLICATION FILING RECEIPT MAILED
Friday, May 21, 2021ASSIGNED TO EXAMINER
Friday, May 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 20, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB